RFP | February 16, 2011
U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute announces the availability of funding for a contractor to identify and evaluate the potential of candidate nanotechnologies to significantly improve the therapeutic index, bioavailability, solubility, and/or pharmacokinetics of otherwise failed anti-cancer agents . . .